Advertisement
Research Article

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma

  • Sheila K. West mail,

    shwest@jhmi.edu

    Affiliation: Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America

    X
  • Robin Bailey,

    Affiliation: London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • Beatriz Munoz,

    Affiliation: Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America

    X
  • Tansy Edwards,

    Affiliation: London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • Harran Mkocha,

    Affiliation: Kongwa Trachoma Project, Kongwa, Tanzania

    X
  • Charlotte Gaydos,

    Affiliation: International Chlamydia Laboratory, Department of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, United States of America

    X
  • Thomas Lietman,

    Affiliation: Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

    X
  • Travis Porco,

    Affiliation: Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America

    X
  • David Mabey,

    Affiliation: London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • Thomas C. Quinn

    Affiliation: Division of Intramural Research, National Institute for Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America

    X
  • Published: August 29, 2013
  • DOI: 10.1371/journal.pntd.0002415

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.